CC BY 4.0 · Rev Bras Ginecol Obstet 2021; 43(11): 862-869
DOI: 10.1055/s-0041-1736304
Review Article

Dyspnea and COVID-19: A Review of Confounding Diagnoses during the Postpartum Period

Dispneia e COVID-19: uma revisão de diagnósticos confundidores no período pós-parto
1   Department of Gynecology and Obstetrics, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
1   Department of Gynecology and Obstetrics, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
1   Department of Gynecology and Obstetrics, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
› Author Affiliations

Abstract

The puerperium is a complex period that begins with placental delivery and lasts for 6 weeks, during which readaptation of the female organism and redistribution of blood volume occur. This period is conducive to the occurrence of thromboembolic events. In the context of the SARS-CoV-2 pandemic, the virus responsible for COVID-19, the attention of the scientific community and health professionals has been focused on obtaining insights on different aspects of this disease, including etiology, transmission, diagnosis, and treatment. Regarding the pregnancy–postpartum cycle, it is opportune to review the clinical conditions that can occur during this period and to investigate dyspnea as a postpartum symptom in order to avoid its immediate association with COVID-19 without further investigation, which can lead to overlooking the diagnosis of other important and occasionally fatal conditions.

Resumo

O puerpério é um período complexo que se inicia com a dequitação placentária e dura por 6 semanas, no qual a readaptação do organismo materno e a redistribuição do volume sanguíneo ocorrem, além de ser também um cenário propício para eventos pró-trombóticos. No contexto da pandemia de SARS-CoV-2, vírus responsável pela COVID-19, a atenção da comunidade científica e dos profissionais da saúde está voltada a elucidar os aspectos da doença, como a etiologia, a transmissão, o diagnóstico e o tratamento. Considerando o ciclo gravídico-puerperal, é oportuna a revisão de condições clínicas que ocorrem durante este período e que apresentam a dispneia como sintoma, a fim de evitar que ela seja automaticamente associada à COVID-19 sem investigações aprofundadas, o que pode levar à negligência do diagnóstico de outras condições importantes e que podem ser, por vezes, fatais.



Publication History

Received: 06 July 2020

Accepted: 30 August 2021

Article published online:
06 December 2021

© 2021. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Hauswaldt J, Blaschke S. [Dyspnea]. Internist (Berl) 2017; 58 (09) 925-936
  • 2 Campbell ML. Dyspnea. Crit Care Nurs Clin North Am 2017; 29 (04) 461-470
  • 3 Poon LC, Yang H, Kapur A, Melamed N, Dao B, Divakar H. et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals. Int J Gynaecol Obstet 2020; 149 (03) 273-286
  • 4 Schwartz DA, Graham AL. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020; 12 (02) 194
  • 5 Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and clinical characteristics of COVID-19. Arch Iran Med 2020; 23 (04) 268-271
  • 6 Meltzer-Brody S, Howard LM, Bergink V, Vigod S, Jones I, Munk-Olsen T. et al. Postpartum psychiatric disorders. Nat Rev Dis Primers 2018; 4: 18022
  • 7 Dado CD, Levinson AT, Bourjeily G. Pregnancy and pulmonary embolism. Clin Chest Med 2018; 39 (03) 525-537
  • 8 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 196: thromboembolism in pregnancy. Obstet Gynecol 2018; 132 (01) e1-e17
  • 9 Goodacre S, Horspool K, Nelson-Piercy C, Knight M, Shepard N, Lecky F. et al; DiPEP research group. The DiPEP study: an observational study of the diagnostic accuracy of clinical assessment, D-dimer and chest x-ray for suspected pulmonary embolism in pregnancy and postpartum. BJOG 2019; 126 (03) 383-392
  • 10 Martillotti G, Boehlen F, Robert-Ebadi H, Jastrow N, Righini M, Blondon M. Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review. J Thromb Haemost 2017; 15 (10) 1942-1950
  • 11 Chunilal SD, Bates SM. Venous thromboembolism in pregnancy: diagnosis, management and prevention. Thromb Haemost 2009; 101 (03) 428-438
  • 12 Grifoni E, Marcucci R, Ciuti G, Cenci C, Poli D, Mannini L. et al. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism. Semin Thromb Hemost 2012; 38 (02) 230-234
  • 13 Hedengran KK, Andersen MR, Stender S, Szecsi PB. Large D-dimer fluctuation in normal pregnancy: a longitudinal cohort study of 4,117 samples from 714 healthy Danish women. Obstet Gynecol Int 2016; 2016: 3561675
  • 14 Touhami O, Marzouk SB, Bennasr L, Touaibia M, Souli I, Felfel MA. et al. Are the Wells Score and the Revised Geneva Score valuable for the diagnosis of pulmonary embolism in pregnancy?. Eur J Obstet Gynecol Reprod Biol 2018; 221: 166-171
  • 15 O'Connor C, Moriarty J, Walsh J, Murray J, Coulter-Smith S, Boyd W. The application of a clinical risk stratification score may reduce unnecessary investigations for pulmonary embolism in pregnancy. J Matern Fetal Neonatal Med 2011; 24 (12) 1461-1464
  • 16 Touqmatchi D, Cotzias C, Girling J. Venous thromboprophylaxis in pregnancy: the implications of changing to the 2010 RCOG guidelines. J Obstet Gynaecol 2012; 32 (08) 743-746
  • 17 Leung AN, Bull TM, Jaeschke R, Lockwood CJ, Boiselle PM, Hurwitz LM. et al; ATS/STR Committee on Pulmonary Embolism in Pregnancy. American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline–Evaluation of Suspected Pulmonary Embolism in Pregnancy. Radiology 2012; 262 (02) 635-646
  • 18 Cunningham FG, Byrne JJ, Nelson DB. Peripartum Cardiomyopathy. Obstet Gynecol 2019; 133 (01) 167-179
  • 19 Koenig T, Hilfiker-Kleiner D, Bauersachs J. Peripartum cardiomyopathy. Herz 2018; 43 (05) 431-437
  • 20 Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ 2019; 364: k5287
  • 21 Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N. et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010; 121 (20) 2176-2182
  • 22 van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bolle IAE, Sliwa K. et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 2014; 35 (32) 2165-2173
  • 23 Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999; 94 (02) 311-316
  • 24 Haghikia A, Röntgen P, Vogel-Claussen J, Schwab J, Westenfeld R, Ehlermann P. et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study. ESC Heart Fail 2015; 2 (04) 139-149
  • 25 Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 2020; 222 (05) 415-426
  • 26 Bulut C, Kato Y. Epidemiology of COVID-19. Turk J Med Sci 2020; 50 (SI-1): 563-570
  • 27 Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T. et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis 2020; 39 (06) 1011-1019
  • 28 Liu D, Li L, Wu X, Zheng D, Wang J, Yang L. et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol 2020; 215 (01) 127-132
  • 29 Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian S. et al. Maternal death due to COVID-19. Am J Obstet Gynecol 2020; 223 (01) 109.e1-109.e16
  • 30 Turan O, Hakim A, Dashraath P, Jeslyn WJL, Wright A, Abdul-Kadir R. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review. Int J Gynaecol Obstet 2020; 151 (01) 7-16
  • 31 Takemoto MLS, Menezes MO, Andreucci CB, Nakamura-Pereira M, Amorim MMR, Katz L. et al. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int J Gynaecol Obstet 2020; 151 (01) 154-156
  • 32 Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 2020; 99 (07) 823-829
  • 33 Carvalho BR, Adami KS, Gonçalves-Ferri WA, Samama M, Ferriani RA, Marcolin AC. COVID-19: uncertainties from conception to birth. Rev Bras Ginecol Obstet 2021; 43 (01) 54-60
  • 34 Boletim Epidemiológico Especial. Doença pelo Coronavírus COVID-19. Brasília (DF): Ministério da Saúde. Secretaria de Vigilância em Saúde; 2020. ;(44)
  • 35 Boletim Epidemiológico Especial. Doença pelo Coronavírus COVID-19. Brasília (DF): Ministério da Saúde. Secretaria de Vigilância em Saúde; 2021. ;(52)
  • 36 Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. AJR Am J Roentgenol 2020; 214 (06) 1280-1286
  • 37 Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135 (23) 2033-2040
  • 38 Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 2020; 55 (05) 105955
  • 39 Covid-19 and pregnancy. BMJ 2020; 369: m1672
  • 40 Dashraath P, Wong JLJ, Lim MXK, Lim MXK, Lim LM, Li S. et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020; 222 (06) 521-531
  • 41 Park JE, Ryu Y. Transmissibility and severity of influenza virus by subtype. Infect Genet Evol 2018; 65: 288-292
  • 42 Beigi RH. Prevention and management of influenza in pregnancy. Obstet Gynecol Clin North Am 2014; 41 (04) 535-546
  • 43 Prasad N, Huang QS, Wood T, Aminisani N, McArthur C, Baker MG. et al. Influenza-Associated outcomes among pregnant, postpartum, and nonpregnant women of reproductive age. J Infect Dis 2019; 219 (12) 1893-1903
  • 44 Mertz D, Geraci J, Winkup J, Gessner BD, Ortiz JR, Loeb M. Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies. Vaccine 2017; 35 (04) 521-528
  • 45 Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J. et al. Maternal immunization: where are we now and how to move forward?. Ann Med 2018; 50 (03) 193-208
  • 46 Bonvin AL, Soccal PM. [Dyspnea: is medical history still useful for its evaluation?]. Rev Med Suisse 2006; 2 (87) 2598-2600 , 2603–2604
  • 47 Clement S, Schauman O, Graham T, Maggioni F, Evans-Lacko S, Bezborodovs N. et al. What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychol Med 2015; 45 (01) 11-27
  • 48 Kushner A, West WP, Pillarisetty LS. Virchow triad. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2020 [cited 2020 Sep 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539697/
  • 49 Sultan AA, West J, Grainge MJ, Riley RD, Tata LJ, Stephansson O. et al. Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study. BMJ 2016; 355: i6253
  • 50 Calvello EJ, Skog AP, Tenner AG, Wallis LA. Applying the lessons of maternal mortality reduction to global emergency health. Bull World Health Organ 2015; 93 (06) 417-423